I can't comment on that as it was before I invested, so I don't know how long they were doing that for.
I recall Dr T saying that recruiting for paed AML can take a very long time as it is a rare disease and even harder to recruit due to the demographic. I can only take his word for it, unless others believe otherwise.
Dr fuller and Dr T has stated there is a lot of interest in EMD aml, so it may be more efficient despite seeming longer.
This is beside the point, I was more referring to the fact that I feel Race is in a stronger position with Amgen(less so whether race actually want to go to approval). But that is my opinion based on limited knowledge
General Comments / Chat, page-4896
-
- There are more pages in this discussion • 6,220 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
0.055(2.92%) |
Mkt cap ! $330.4M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.96 | $1.85 | $333.0K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3105 | $1.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 7574 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |